Koji Kaneko
Niigata, 9518566, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Recurrence prediction of invasive ductal carcinoma from preoperative contrast-enhanced computed tomography using deep convolutional neural network.
Journal: Biomedical physics & engineering express
Published: February 28, 2025
Prefectural Survey on Anthracycline-Related Cardiomyopathy at the Start of the Basic Plan to Promote Cancer Control Programs - Phase 4.
Journal: Circulation reports
Published: January 07, 2025
Increasing survivors of anthracycline-related cardiomyopathy with breast cancer in trastuzumab era: thirty-one-year trends in a Japanese Community.
Journal: Breast cancer (Tokyo, Japan)
Published: April 19, 2024
Clinical features of skin metastasis from breast cancer: A retrospective observational study in Japan.
Journal: The Journal of dermatology
Published: January 27, 2024
Patients Offer Radiofrequency Ablation Therapy for Early Breast Cancer as Local Therapy (PO-RAFAELO) Study under the Patient-proposed Health Services.
Journal: JMA journal
Published: March 28, 2023
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients.
Journal: Breast cancer (Tokyo, Japan)
Published: October 27, 2022
Efficacy and exploratory biomarker analysis of entinostat plus exemestane in advanced or recurrent breast cancer: phase II randomized controlled trial.
Journal: Japanese journal of clinical oncology
Published: March 31, 2022
Evaluation of a novel medical device for pegfilgrastim administration.
Journal: Cancer science
Published: December 14, 2021
A prediction model for early systemic recurrence in breast cancer using a molecular diagnostic analysis of sentinel lymph nodes: A large-scale, multicenter cohort study.
Journal: Cancer
Published: November 10, 2021
A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer.
Journal: Breast cancer research and treatment
Published: November 25, 2019
Corrigendum to: Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130).
Journal: Japanese journal of clinical oncology
Published: May 28, 2019
Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130).
Journal: Japanese journal of clinical oncology
Published: May 28, 2019
Last Updated: 09/26/2026